C3.ai Inc vs Cytokinetics Inc — how do they compare? C3.ai Inc trades at $10.59 (market cap $1.65B), while Cytokinetics Inc trades at $77.39 (market cap $10.63B). The key difference: Cytokinetics Inc is far larger — about 6.4× C3.ai Inc's market cap, and Cytokinetics Inc is trading nearer its 52-week high, C3.ai Inc nearer its low. Which is the better fit depends on your goals.
| AI | CYTK | |
|---|---|---|
Market Cap | $1.65B | $10.63B |
Sector | Technology | Technology |
52-Week High | $19.66 | $87.26 |
52-Week Low | $7.76 | $34.31 |
Enterprise Value | $1.08B | $10.74B |
Trailing returns across standard periods
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →